The insider trading trial of Segantii Capital Management came to a halt on Tuesday, following more than a month of testimony that put a magnifying glass on a tiny series of trades that took place almost a decade ago.
The insider trading trial of Segantii Capital Management came to a halt on Tuesday, following more than a month of testimony that put a magnifying glass on a tiny series of trades that took place almost a decade ago.
<iframe src="https://statesidedaily.com/embed/cluster/8c8876d45f5e6eee4632b9d1c6c757b77a54b945" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Segantii Trial Enters Endgame as Defense Wraps Up Testimony"></iframe>
